Massive german registry aims to unlock secrets of IBD care

NCT ID NCT07319442

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a large registry that will follow 10,000 people with inflammatory bowel disease (IBD) in Germany over many years. Its goal is to collect real-world information on how well treatments work, how the disease changes over time, and how it affects patients' daily lives. No new treatments are being tested—instead, researchers will observe routine care to improve future management of Crohn's disease and ulcerative colitis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ImmunoRegister gUG

    RECRUITING

    Hamburg, 20251, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.